Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
400 participants
OBSERVATIONAL
2022-09-01
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Reversal of Defunctioning Stoma Trial
NCT00640913
Surviving Rectal Cancer at the Cost of a Colostomy International Validation of the Colostomy Impact Score
NCT03516916
Inflammation After Laparoscopic Robot-assisted Surgery for Locally Advanced Rectal Cancer
NCT04324567
Retrospective Study of Surgical Complications in Patients With Defunctioning Stoma After Low Anterior Resection (LAR)
NCT04359498
Reconstruction After Abdominoperineal Resection With Robot-assisted Harvest of VRAM Flap
NCT05689775
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Rectal resection with diverting stoma
Patients operated for rectal cancer with rectal resection and diverting stoma.
Rectal resection with diverting stoma
Patients in this group will receive a rectal resection with an anastomosis and also a diverting stoma will be created
Rectal resection without diverting stoma
Patients operated for rectal cancer with rectal resection without diverting stoma.
Rectal resection without diverting stoma
Patients in this group will receive a rectal resection with an anastomosis and no diverting stoma will be created
Rectal resection with primary colostomy
Patients operated for rectal cancer with rectal resection with primary colostomy.
Rectal resection with permanent colostomy
Patients in this group will receive a rectal resection and a permanent colostomy will be created
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rectal resection with diverting stoma
Patients in this group will receive a rectal resection with an anastomosis and also a diverting stoma will be created
Rectal resection without diverting stoma
Patients in this group will receive a rectal resection with an anastomosis and no diverting stoma will be created
Rectal resection with permanent colostomy
Patients in this group will receive a rectal resection and a permanent colostomy will be created
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Verified rectal adenocarcinoma by biopsy
* Tumor located in the rectum with lower border of the tumor located 15 cm or less from the anal verge.
* Given informed consent
Exclusion Criteria
* Stage IV disease
* Synchronous colon cancer necessitating a total colectomy
* Other concomitant disease(s) which will complicate participation.
* Unwillingness to give informed consent
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Haukeland University Hospital
OTHER
University Hospital of North Norway
OTHER
Helse Nord-Trøndelag HF
OTHER
St. Olavs Hospital
OTHER
Alesund Hospital
OTHER
Helse Fonna
OTHER
Helse Stavanger HF
OTHER_GOV
Sorlandet Hospital HF
OTHER_GOV
Sykehuset Telemark
OTHER_GOV
Vestre Viken Hospital Trust
OTHER
Asker & Baerum Hospital
OTHER
Ullevaal University Hospital
OTHER
Oslo University Hospital
OTHER
Ostfold Hospital Trust
OTHER
University Hospital, Akershus
OTHER
Hamar Hospital
UNKNOWN
Gjøvik Hospital
UNKNOWN
Bodø Hospital
UNKNOWN
The Hospital of Vestfold
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lars Thomas
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lars Thomas Seeberg, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
The Hospital of Vestfold
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asker og Baerum Hospital
Bærums verk, Gjettum, Norway
Østfold Hospital Trust
Sarpsborg, Grålum, Norway
Akershus University Hospital
Oslo, Lørenskog, Norway
Ålesund Hospital
Ålesund, , Norway
Haukeland University Hospital
Bergen, , Norway
Bodø Hospital
Bodø, , Norway
Vestre Viken Hospital Trust
Drammen, , Norway
Gjøvik Hospital
Gjøvik, , Norway
Hamar Hospital
Hamar, , Norway
Helse Fonna
Haugesund, , Norway
Sorlandet Hospital HF
Kristiansand, , Norway
Helse Nord-Trøndelag HF
Levanger, , Norway
Ullevaal University Hospital
Oslo, , Norway
Sykehuset Telemark
Skien, , Norway
Helse Stavanger HF
Stavanger, , Norway
University Hospital of North Norway
Tromsø, , Norway
St. Olavs Hospital
Trondheim, , Norway
Vestfold Hospital Trust
Tønsberg, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mathias Irgens, MD
Role: primary
Silje Sanengen, MD
Role: primary
Thomas Heggelund, MD
Role: primary
Thomas Nygaard, MD
Role: primary
Håvard Forsmo, MD, PhD
Role: primary
Kåre Nordland, MD
Role: primary
Johan Bondi, MD, PhD
Role: primary
Alexander Frodahl, MD
Role: primary
Jan Lambrecht, MD, PhD
Role: primary
Håvard Thorsen, MD
Role: primary
Martin Bøhler, MD
Role: primary
Eivor Laugsand, MD, PhD
Role: primary
Usman Saeed, MD
Role: primary
Silje Holte, MD
Role: primary
Ragnar Herikstad, MD
Role: primary
Martin Hagve, MD
Role: primary
Tore Stornes, MD, PhD
Role: primary
Lars Grønvold, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21/05179
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.